AI-generated summary
The authors exposed astrocytoma-derived CNS-1 cells in vitro to low-level light at several doses and wavelengths before photodynamic therapy. They report that low-level light increased expression of peripheral-type mitochondrial benzodiazepine receptors and protoporphyrin IX, with greater cell kill than photodynamic therapy alone. The study was conducted only on cultured cells, not in patients or animals.
- Who or what was studied
- Astrocytoma-derived CNS-1 glioma cells cultured in vitro
- Wavelengths
- 600, 800, 635, 905 nm
- Limits stated in the abstract
- The study was conducted only on cultured tumor cells in vitro, so the findings do not establish effects in patients or in living tissue.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600-800 nm, 905 nm, 635 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Photodynamic therapy, Wavelength, Mitochondria, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.